Long-acting injectable multipurpose prevention technology for prevention of HIV and unplanned pregnancy-Reference-Cited by-同舟云学术

Long-acting injectable multipurpose prevention technology for prevention of HIV and unplanned pregnancy

Published:2023-11 Issue: Volume:363 Page:606-620
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Young Isabella C.,Pallerla Aryani,Cottrell Mackenzie L.,Maturavongsadit Panita,Prasher Alka,Shrivastava Roopali,De la Cruz Gabriela,Montgomery Stephanie A.,Schauer Amanda,Sykes Craig,Kashuba Angela D.M.,Benhabbour S. Rahima

Funder

National Science Foundation

National Institutes of Health

National Institute of Allergy and Infectious Diseases

National Center for Advancing Translational Sciences

Institute of Clinical and Translational Sciences

North Carolina Translational and Clinical Sciences Institute, University of North Carolina at Chapel Hill

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference62 articles.

1. The Global HIV/AIDS Epidemic,2021

2. CDC: Unintended Pregnancy,2021

3. Global HIV & AIDS Statistics — 2021 Fact Sheet, in;UNAIDS,2021

4. Drug delivery strategies and systems for HIV/AIDS pre-exposure prophylaxis and treatment;Nelson;J. Control. Release,2015

5. Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial;Landovitz;Lancet HIV,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Situ Forming, Enzyme-Responsive Peptoid-Peptide Hydrogels: An Advanced Long-Acting Injectable Drug Delivery System;Journal of the American Chemical Society;2024-06-26